CN101065386A - 亚烷基－四氢化萘衍生物、其制备方法及其作为抗炎药物的应用 - Google Patents
亚烷基－四氢化萘衍生物、其制备方法及其作为抗炎药物的应用 Download PDFInfo
- Publication number
- CN101065386A CN101065386A CNA2005800383722A CN200580038372A CN101065386A CN 101065386 A CN101065386 A CN 101065386A CN A2005800383722 A CNA2005800383722 A CN A2005800383722A CN 200580038372 A CN200580038372 A CN 200580038372A CN 101065386 A CN101065386 A CN 101065386A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- group
- hydroxyl
- optionally
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004044680.6 | 2004-09-09 | ||
| DE102004044680A DE102004044680B3 (de) | 2004-09-09 | 2004-09-09 | Alkyliden-Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101065386A true CN101065386A (zh) | 2007-10-31 |
Family
ID=35517445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005800383722A Pending CN101065386A (zh) | 2004-09-09 | 2005-09-02 | 亚烷基－四氢化萘衍生物、其制备方法及其作为抗炎药物的应用 |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1786823B1 (enExample) |
| JP (1) | JP2008512416A (enExample) |
| KR (1) | KR20070050469A (enExample) |
| CN (1) | CN101065386A (enExample) |
| AR (1) | AR050733A1 (enExample) |
| AT (1) | ATE384069T1 (enExample) |
| AU (1) | AU2005281859A1 (enExample) |
| BR (1) | BRPI0515186A (enExample) |
| CA (1) | CA2577861A1 (enExample) |
| DE (2) | DE102004044680B3 (enExample) |
| EA (1) | EA200700550A1 (enExample) |
| EC (1) | ECSP077306A (enExample) |
| ES (1) | ES2301056T3 (enExample) |
| GT (1) | GT200500241A (enExample) |
| IL (1) | IL181832A0 (enExample) |
| MX (1) | MX2007002833A (enExample) |
| NO (1) | NO20071805L (enExample) |
| PA (1) | PA8644701A1 (enExample) |
| PE (1) | PE20060596A1 (enExample) |
| RS (1) | RS20070095A (enExample) |
| SV (1) | SV2006002220A (enExample) |
| TW (1) | TW200621703A (enExample) |
| UY (1) | UY29109A1 (enExample) |
| WO (1) | WO2006027236A1 (enExample) |
| ZA (1) | ZA200701399B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7662821B2 (en) | 2003-10-08 | 2010-02-16 | Bayer Schering Pharma Ag | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| US7638515B2 (en) | 2003-10-08 | 2009-12-29 | Bayer Schering Pharma Aktiengesellschaft | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| SI1670458T1 (sl) | 2003-10-08 | 2007-06-30 | Bayer Schering Pharma Ag | Tetrahidronaftalenski derivati, postopek za njihovo pripravo in njihova uporaba kot antiinflamatoriki |
| US20080153859A1 (en) | 2004-04-05 | 2008-06-26 | Hartmut Rehwinkel | Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| DE102004063227A1 (de) * | 2004-12-22 | 2006-07-06 | Schering Ag | Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| EP1834948A1 (de) | 2006-03-15 | 2007-09-19 | Bayer Schering Pharma Aktiengesellschaft | Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| EP1917963A1 (en) * | 2006-10-31 | 2008-05-07 | Bayer Schering Pharma Aktiengesellschaft | Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents |
| CA2678615A1 (en) | 2007-02-16 | 2008-08-28 | Synta Pharmaceutical Corp. | Substituted fused-ring compounds for inflammation and immune-related uses |
| EP2072509A1 (en) | 2007-12-18 | 2009-06-24 | Bayer Schering Pharma Aktiengesellschaft | 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU698527B2 (en) * | 1994-12-29 | 1998-10-29 | Allergan, Inc. | Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| DE10038639A1 (de) * | 2000-07-28 | 2002-02-21 | Schering Ag | Nichtsteroidale Entzündungshemmer |
| ES2298508T3 (es) * | 2002-03-26 | 2008-05-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos. |
| DE10215316C1 (de) * | 2002-04-02 | 2003-12-18 | Schering Ag | Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer |
| SI1670458T1 (sl) * | 2003-10-08 | 2007-06-30 | Bayer Schering Pharma Ag | Tetrahidronaftalenski derivati, postopek za njihovo pripravo in njihova uporaba kot antiinflamatoriki |
-
2004
- 2004-09-09 DE DE102004044680A patent/DE102004044680B3/de not_active Expired - Fee Related
-
2005
- 2005-09-02 CA CA002577861A patent/CA2577861A1/en not_active Abandoned
- 2005-09-02 BR BRPI0515186-4A patent/BRPI0515186A/pt not_active Application Discontinuation
- 2005-09-02 MX MX2007002833A patent/MX2007002833A/es not_active Application Discontinuation
- 2005-09-02 AU AU2005281859A patent/AU2005281859A1/en not_active Abandoned
- 2005-09-02 RS RSP-2007/0095A patent/RS20070095A/sr unknown
- 2005-09-02 DE DE502005002595T patent/DE502005002595D1/de not_active Expired - Fee Related
- 2005-09-02 KR KR1020077005549A patent/KR20070050469A/ko not_active Withdrawn
- 2005-09-02 CN CNA2005800383722A patent/CN101065386A/zh active Pending
- 2005-09-02 AT AT05786302T patent/ATE384069T1/de not_active IP Right Cessation
- 2005-09-02 EP EP05786302A patent/EP1786823B1/de not_active Expired - Lifetime
- 2005-09-02 JP JP2007530646A patent/JP2008512416A/ja not_active Withdrawn
- 2005-09-02 WO PCT/EP2005/009623 patent/WO2006027236A1/de not_active Ceased
- 2005-09-02 ES ES05786302T patent/ES2301056T3/es not_active Expired - Lifetime
- 2005-09-02 GT GT200500241A patent/GT200500241A/es unknown
- 2005-09-02 EA EA200700550A patent/EA200700550A1/ru unknown
- 2005-09-06 TW TW094130577A patent/TW200621703A/zh unknown
- 2005-09-08 PE PE2005001041A patent/PE20060596A1/es not_active Application Discontinuation
- 2005-09-08 UY UY29109A patent/UY29109A1/es not_active Application Discontinuation
- 2005-09-08 SV SV2005002220A patent/SV2006002220A/es not_active Application Discontinuation
- 2005-09-08 PA PA20058644701A patent/PA8644701A1/es unknown
- 2005-09-09 AR ARP050103762A patent/AR050733A1/es unknown
-
2007
- 2007-02-16 ZA ZA200701399A patent/ZA200701399B/xx unknown
- 2007-03-08 IL IL181832A patent/IL181832A0/en unknown
- 2007-03-08 EC EC2007007306A patent/ECSP077306A/es unknown
- 2007-04-03 NO NO20071805A patent/NO20071805L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2577861A1 (en) | 2006-03-16 |
| WO2006027236A1 (de) | 2006-03-16 |
| PA8644701A1 (es) | 2006-07-03 |
| IL181832A0 (en) | 2007-07-04 |
| UY29109A1 (es) | 2006-03-31 |
| BRPI0515186A (pt) | 2008-07-22 |
| RS20070095A (sr) | 2008-11-28 |
| ECSP077306A (es) | 2007-04-26 |
| ATE384069T1 (de) | 2008-02-15 |
| KR20070050469A (ko) | 2007-05-15 |
| JP2008512416A (ja) | 2008-04-24 |
| DE502005002595D1 (de) | 2008-03-06 |
| NO20071805L (no) | 2007-06-07 |
| EP1786823B1 (de) | 2008-01-16 |
| AR050733A1 (es) | 2006-11-15 |
| SV2006002220A (es) | 2006-03-15 |
| AU2005281859A1 (en) | 2006-03-16 |
| PE20060596A1 (es) | 2006-07-26 |
| EA200700550A1 (ru) | 2007-10-26 |
| DE102004044680B3 (de) | 2006-06-08 |
| TW200621703A (en) | 2006-07-01 |
| ES2301056T3 (es) | 2008-06-16 |
| ZA200701399B (en) | 2008-09-25 |
| MX2007002833A (es) | 2007-07-09 |
| GT200500241A (es) | 2006-08-17 |
| EP1786823A1 (de) | 2007-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1659144A (zh) | 喹啉和异喹啉衍生物、其制备方法以及作为炎症抑制剂的应用 | |
| CN1190432C (zh) | 作为5－htib拮抗药的哌嗪衍生物 | |
| CN1169795C (zh) | 环胺取代的含氮杂环化合物及其组合物 | |
| CN1444570A (zh) | 非甾体抗炎药 | |
| CN1867555A (zh) | 重排的戊醇,其制备方法以及它们作为抗炎药物的应用 | |
| CN1017242B (zh) | 新的喹唑啉衍生物的制备方法 | |
| CN1094043A (zh) | 喹唑啉衍生物 | |
| CN1334809A (zh) | 非甾体抗炎药 | |
| CN1492860A (zh) | 喹唑啉衍生物 | |
| CN1829711A (zh) | 用于治疗炎性和过敏性病症的新杂环化合物、其制备方法和含有它们的药物组合物 | |
| CN1071164A (zh) | 含氮杂环化合物 | |
| CN1063869A (zh) | 新的含氮双环衍生物，其制备方法，由此得到的新的中间体，其药物用途和含这类物质的药物组合物 | |
| CN1161337C (zh) | 喹啉酮衍生物、其制备方法和抗变态反应剂 | |
| CN1310890C (zh) | 异喹啉衍生物 | |
| CN1158129A (zh) | 具有cgmp-磷酸二酯酶抑制活性的新苯并咪唑衍生物 | |
| CN87103504A (zh) | 杂环羧酰胺 | |
| CN1922170A (zh) | 新的羟基－6－杂芳基菲啶及其作为pde4 | |
| CN101065386A (zh) | 亚烷基－四氢化萘衍生物、其制备方法及其作为抗炎药物的应用 | |
| CN1240684C (zh) | 二苯并环庚烯化合物 | |
| CN1293074C (zh) | 具有pde抑制活性的芳基茚并吡啶 | |
| CN1158265C (zh) | 喹啉酮衍生物以及含有所述喹啉酮衍生物作活性成分的抗过敏剂 | |
| CN1505624A (zh) | 哌嗪子基衍生物及其作为pde4抑制剂的用途 | |
| CN1107838A (zh) | 三环吲哚-2-羧酸衍生物 | |
| CN1349527A (zh) | 取代的苯并内酰胺化合物 | |
| HK1109902A (en) | Alkylidene tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1109902 Country of ref document: HK |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071031 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1109902 Country of ref document: HK |